XML 14 R3.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
REVENUES $ 4,670 $ 1,336 $ 7,118 $ 4,364
COST OF REVENUES (4,248) (223) (6,446) (730)
GROSS PROFIT 422 1,113 672 3,634
RESEARCH AND DEVELOPMENT EXPENSES [1] (6,353) (5,068) (23,700) (17,191)
Less - grants 1,297 1,116 4,800 3,573
RESEARCH AND DEVELOPMENT EXPENSES, NET (5,056) (3,952) (18,900) (13,618)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES [1] (2,014) (2,163) (6,215) (5,986)
OPERATING LOSS (6,648) (5,002) (24,443) (15,970)
FINANCIAL EXPENSES (910) (1,030) (2,715) (2,805)
FINANCIAL INCOME 268 17 606 64
FINANCIAL EXPENSES - NET (642) (1,013) (2,109) (2,741)
LOSS FROM CONTINUING OPERATIONS (7,290) (6,015) (26,552) (18,711)
(LOSS) INCOME FROM DISCONTINUED OPERATIONS 0 2,195 (189) 3,848
NET LOSS FOR THE PERIOD $ (7,290) $ (3,820) $ (26,741) $ (14,863)
NET LOSS PER SHARE OF COMMON STOCK - BASIC AND DILUTED:        
loss from continuing operations $ (0.07) $ (0.06) $ (0.27) $ (0.2)
Income (loss) from discontinued operations 0 0.02 0 0.04
Net loss per share of common stock $ (0.07) $ (0.04) $ (0.27) $ (0.16)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - BASIC AND DILUTED: (in shares) 99,821,970 93,943,772 99,766,245 93,599,414
[1] Includes share-based compensation